UNSPECIFIED INGREDIENT for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 186 adverse event reports in the FDA FAERS database where UNSPECIFIED INGREDIENT was used for Malignant melanoma.
Most Reported Side Effects for UNSPECIFIED INGREDIENT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,090 | 8.0% | 2,089 | 308 |
| Off label use | 1,306 | 5.0% | 324 | 483 |
| Drug ineffective | 1,227 | 4.7% | 154 | 338 |
| Completed suicide | 1,190 | 4.6% | 1,189 | 170 |
| Nausea | 1,041 | 4.0% | 234 | 514 |
| Fatigue | 1,020 | 3.9% | 167 | 402 |
| Dyspnoea | 934 | 3.6% | 270 | 594 |
| Pneumonia | 903 | 3.5% | 310 | 719 |
| Asthenia | 894 | 3.4% | 237 | 506 |
| Vomiting | 877 | 3.4% | 244 | 528 |
| Diarrhoea | 821 | 3.1% | 152 | 457 |
| Pain | 701 | 2.7% | 128 | 299 |
| Dizziness | 692 | 2.6% | 88 | 283 |
| Headache | 681 | 2.6% | 125 | 261 |
| Pyrexia | 658 | 2.5% | 140 | 499 |
Other Indications for UNSPECIFIED INGREDIENT
Product used for unknown indication (6,768)
Rheumatoid arthritis (394)
Non-small cell lung cancer (276)
Cardiac failure (261)
Type 2 diabetes mellitus (229)
Diffuse large b-cell lymphoma (210)
Covid-19 (207)
Hiv infection (185)
Suspected suicide (172)
Anticoagulant therapy (166)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)